NCT02872012View on ClinicalTrials.gov

Cryoanesthesia for Intravitreal Injections

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Ocular Anesthesia
Interventions
DEVICE

Cryoanesthesia device

The study will be carried out in patients receiving bilateral injections. One eye will be anesthetized using the cryoanesthesia device, developed at the University of Michigan. This has been assessed to be a Non-significant Risk device.

DRUG

Lidocaine

Lidocaine applied to the non-cryoanesthesia eye.

Trial Locations (1)

48105

Kellogg Eye Center, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT02872012 - Cryoanesthesia for Intravitreal Injections | Biotech Hunter | Biotech Hunter